Previous session detected
Resume Quiz
An Evidence-Based Examination of Administration of
Infliximab 0761-9999-18-355-H01-P&T Non-Member
10 Questions
Remicade (Infliximab [IFX]), the first tumor necrosis factor-alpha (TNF-α) antagonist approved by the U.S. Food and Drug Administration (FDA), has become one of the most prescribed biologic agents in the country and a mainstay of the home infusion industry. Safe administration requires a comprehensive knowledge the mechanism of action and prescribing information, as well as the ability to manage and prevent infusion reactions.